Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABCHIX:SYNSAS 85 EV-to-EBIT is 10.89 as of Aug. 21, 2026, which is 20% below its 10-year median of 13.55. GuruFocus rates CHIX:SYNSAS with a GF Score™ of 85/100 and a GF Value™ of kr65.82. The stock has 1 warning sign investors should review. Among 473 Medical Devices & Instruments companies, Synsam AB ranks better than 73.78% on this metric.
The historical rank and industry rank for Synsam AB's EV-to-EBIT or its related term are showing as below:
CHIX:SYNSAs'
s EV-to-EBIT Range Over the Past 10 Years
Min: 9.92 Med: 13.55 Max: 24.67
Current: 10.89
During the past 8 years, the highest EV-to-EBIT of Synsam AB was 24.67. The lowest was 9.92. And the median was 13.55.
CHIX:SYNSAs's EV-to-EBIT is ranked better than 73.78% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 18.87
vs CHIX:SYNSAs: 10.89
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Synsam AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr11,383 Mil.
Synsam AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,013 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synsam AB EV-to-EBIT Related Terms
Synsam AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Synsam AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SYNSAS vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Synsam AB's EV-to-EBIT falls into.
Synsam AB's current Enterprise Value is kr11,032 Mil.
Synsam AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,013 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synsam AB (CHIX:SYNSAS) has a EV-to-EBIT of 10.89 as of Aug. 21, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Synsam AB and its competitors. This is 20% below median its historical median of 13.55. Over the past decade, Synsam AB's EV-to-EBIT has ranged from 9.92 to 24.67. According to the industry distribution chart, Synsam AB ranks #124 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 26.2%.
Is Synsam AB's EV-to-EBIT too high?
Synsam AB's current EV-to-EBIT of 10.89 is 20% below median its 10-year median of 13.55. Over the past 10 years, this metric has ranged from a low of 9.92 to a high of 24.67. The Medical Devices & Instruments industry median EV-to-EBIT is 18.87. Synsam AB's value of 10.89 is 42.3% below this industry median. Based on the distribution chart, Synsam AB ranks #124 out of 473 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Synsam AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #124 out of 473 companies for EV-to-EBIT. This puts Synsam AB in the upper half of its industry. The industry median EV-to-EBIT is 18.87. Synsam AB's value of 10.89 is 42.3% below this benchmark. Historically, Synsam AB's own EV-to-EBIT has ranged from 9.92 to 24.67 over the past decade. While the company's 10-year median is 13.55 vs. the industry median of 18.87, Synsam AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.87, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current EV-to-EBIT of 10.89 is 42.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Synsam AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current EV-to-EBIT is 10.89, which is 20% below median its own 10-year median of 13.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current EV-to-EBIT of 10.89. The stock's GF Value™ is kr65.82, compared to a current price of kr59.80 — trading 9.1% below its estimated fair value. The current EV-to-EBIT is 10.89, which is 20% below median its 10-year median of 13.55 and 42.3% below the Medical Devices & Instruments industry median of 18.87. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current EV-to-EBIT is 10.89 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr59.80 is trading 9.1% below its estimated GF Value™ of kr65.82.
Key valuation signals for CHIX:SYNSAS:
EV-to-EBIT: 10.89 (20% below median its 10-year median of 13.55)
GF Value™: kr65.82 vs. price of kr59.80 (9.1% below fair value)
Industry Position: 42.3% below the Medical Devices & Instruments median (#124 of 473)
No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score
Get the complete analysis for CHIX:SYNSAS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SYNSAS has been successfully added to your 
